share_log

Adicet Bio Analyst Ratings

Adicet Bio Analyst Ratings

Adicet 生物分析师评级
Benzinga ·  2023/11/09 10:42
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
11/09/2023 293.7% Wedbush $17 → $5 Maintains Outperform
09/06/2023 2025.98% Truist Securities → $27 Reiterates Buy → Buy
08/11/2023 1947.24% HC Wainwright & Co. $38 → $26 Maintains Buy
08/10/2023 687.4% BTIG $20 → $10 Maintains Buy
08/10/2023 1238.58% Wedbush → $17 Reiterates Outperform → Outperform
06/27/2023 1474.8% Guggenheim → $20 Downgrades Buy → Neutral
06/27/2023 2892.13% HC Wainwright & Co. → $38 Reiterates Buy → Buy
06/27/2023 — JMP Securities Downgrades Market Outperform → Market Perform
06/01/2023 372.44% JP Morgan $20 → $6 Downgrades Overweight → Neutral
05/15/2023 1396.06% JMP Securities → $19 Reiterates Market Outperform → Market Outperform
05/10/2023 2262.2% Wedbush → $30 Reiterates → Outperform
05/10/2023 2892.13% HC Wainwright & Co. → $38 Maintains Buy
03/16/2023 2262.2% Wedbush → $30 Reiterates → Outperform
03/16/2023 2892.13% HC Wainwright & Co. → $38 Reiterates → Buy
12/12/2022 2892.13% HC Wainwright & Co. $34 → $38 Maintains Buy
09/21/2022 1711.02% JP Morgan → $23 Initiates Coverage On → Overweight
03/31/2022 2104.72% SMBC Nikko → $28 Initiates Coverage On → Outperform
03/17/2022 1553.54% JMP Securities $30 → $21 Maintains Market Outperform
03/08/2022 2262.2% Truist Securities → $30 Initiates Coverage On → Buy
03/04/2022 2025.98% Jefferies → $27 Initiates Coverage On → Buy
12/06/2021 2419.69% Guggenheim $22 → $32 Maintains Buy
05/18/2021 2577.17% BTIG → $34 Initiates Coverage On → Buy
04/29/2021 2498.43% JonesTrading → $33 Initiates Coverage On → Buy
04/23/2021 2025.98% HC Wainwright & Co. → $27 Initiates Coverage On → Buy
04/14/2021 2104.72% Canaccord Genuity → $28 Initiates Coverage On → Buy
04/08/2021 1632.28% Guggenheim → $22 Initiates Coverage On → Buy
11/04/2020 2262.2% B. Riley Securities → $30 Initiates Coverage On → Buy
10/16/2020 1868.5% Wedbush → $25 Initiates Coverage On → Outperform
日期 上行/下行 分析公司 目标价格变动 评级变动 之前/当前的评级
11/09/2023 293.7% Wedbush 17 美元 → 5 美元 维护 跑赢大盘
09/06/2023 2025.98% Truist 证券 → 27 美元 重申 购买 → 购买
08/11/2023 1947.24% HC Wainwright & Co. 38 美元 → 26 美元 维护 买
08/10/2023 687.4% BTIG 20 美元 → 10 美元 维护 买
08/10/2023 1238.58% Wedbush → 17 美元 重申 跑赢大盘 → 跑赢大盘
06/27/2023 1474.8% 古根海姆 → 20 美元 降级 买入 → 中性
06/27/2023 2892.13% HC Wainwright & Co. → 38 美元 重申 购买 → 购买
06/27/2023 — JMP 证券 降级 市场跑赢大盘 → 市场表现
06/01/2023 372.44% 摩根大通 20 美元 → 6 美元 降级 超重 → 中性
05/15/2023 1396.06% JMP 证券 → 19 美元 重申 市场跑赢大盘 → 市场跑赢大盘
05/10/2023 2262.2% Wedbush → 30 美元 重申 → 跑赢大盘
05/10/2023 2892.13% HC Wainwright & Co. → 38 美元 维护 买
03/16/2023 2262.2% Wedbush → 30 美元 重申 → 跑赢大盘
03/16/2023 2892.13% HC Wainwright & Co. → 38 美元 重申 → 购买
2022 年 12 月 12 日 2892.13% HC Wainwright & Co. 34 美元 → 38 美元 维护 买
09/21/2022 1711.02% 摩根大通 → 23 美元 启动覆盖范围开启 → 超重
03/31/2022 2104.72% 三井住友银行日光 → 28 美元 启动覆盖范围开启 → 跑赢大盘
03/17/2022 1553.54% JMP 证券 30 美元 → 21 美元 维护 市场表现跑赢大盘
03/08/2022 2262.2% Truist 证券 → 30 美元 启动覆盖范围开启 → 购买
03/04/2022 2025.98% 杰富瑞集团 → 27 美元 启动覆盖范围开启 → 购买
12/06/2021 2419.69% 古根海姆 22 美元 → 32 美元 维护 买
05/18/2021 2577.17% BTIG → 34 美元 启动覆盖范围开启 → 购买
04/29/2021 2498.43% JonesTrading → 33 美元 启动覆盖范围开启 → 购买
2021 年 4 月 23 日 2025.98% HC Wainwright & Co. → 27 美元 启动覆盖范围开启 → 购买
2021 年 4 月 14 日 2104.72% Canaccord Genu → 28 美元 启动覆盖范围开启 → 购买
2021 年 8 月 4 日 1632.28% 古根海姆 → 22 美元 启动覆盖范围开启 → 购买
11/04/2020 2262.2% B. 莱利证券 → 30 美元 启动覆盖范围开启 → 购买
10/16/2020 1868.5% Wedbush → 25 美元 启动覆盖范围开启 → 跑赢大盘

What is the target price for Adicet Bio (ACET)?

Adicet Bio（ACET）的目标价格是多少？

The latest price target for Adicet Bio (NASDAQ: ACET) was reported by Wedbush on November 9, 2023. The analyst firm set a price target for $5.00 expecting ACET to rise to within 12 months (a possible 293.70% upside). 15 analyst firms have reported ratings in the last year.

Wedbush于2023年11月9日公布了Adicet Bio（纳斯达克股票代码：ACET）的最新目标股价。该分析公司将目标股价定为5.00美元，预计ACET将在12个月内升至12个月内（可能上涨293.70％）。去年有15家分析公司公布了评级。

What is the most recent analyst rating for Adicet Bio (ACET)?

分析师对Adicet Bio（ACET）的最新评级是多少？

The latest analyst rating for Adicet Bio (NASDAQ: ACET) was provided by Wedbush, and Adicet Bio maintained their outperform rating.

Wedbush提供了Adicet Bio（纳斯达克股票代码：ACET）的最新分析师评级，Adicet Bio维持了跑赢大盘的评级。

When is the next analyst rating going to be posted or updated for Adicet Bio (ACET)?

Adicet Bio（ACET）的下一个分析师评级何时公布或更新？

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Adicet Bio, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Adicet Bio was filed on November 9, 2023 so you should expect the next rating to be made available sometime around November 9, 2024.

分析师在进行了广泛的研究后得出了股票评级，其中包括浏览公开财务报表，与Adicet Bio的高管和客户交谈，以及听取财报电话会议。大多数分析师每三个月做一次这样的评级，因此每家公司每年应该获得4次评级。Adicet Bio的最新评级是在2023年11月9日发布的，因此您应该预计下一个评级将在2024年11月9日左右公布。

Is the Analyst Rating Adicet Bio (ACET) correct?

分析师对Adicet Bio（ACET）的评级正确吗？

While ratings are subjective and will change, the latest Adicet Bio (ACET) rating was a maintained with a price target of $17.00 to $5.00. The current price Adicet Bio (ACET) is trading at is $1.27, which is out of the analyst's predicted range.

尽管评级是主观的，并且会发生变化，但最新的Adicet Bio（ACET）评级保持不变，目标股价为17.00美元至5.00美元。Adicet Bio（ACET）目前的交易价格为1.27美元，超出了分析师的预期区间。

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发